Rhumbline Advisers Legend Biotech Corp Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Legend Biotech Corp stock. As of the latest transaction made, Rhumbline Advisers holds 26,094 shares of LEGN stock, worth $855,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,094
Previous 26,334
0.91%
Holding current value
$855,361
Previous $1.17 Million
9.01%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$366 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$246 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$218 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$188 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$165 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.49B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...